Class Labeling Issues Could Speed Adoption Of New Highlights Format
Executive Summary
Manufacturers may have an incentive to reformat labeling of their products sooner than would otherwise be required to prevent competing firms from setting the standard for the new Highlights section, FDA Office of Medical Policy Director Robert Temple suggested